Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcium chloride dihydrate + dextrose monohydrate + potassium chloride + sodium chloride + sodium lactate is a fixed-dose intravenous parenteral fluid, electrolyte, and carbohydrate solution commonly labeled as Lactated Ringer's and Dextrose (5%) Injection. It provides water, sodium, chloride, potassium, calcium, lactate, and dextrose for replacement of extracellular fluid and electrolyte losses and for limited caloric support. Lactate is metabolized to bicarbonate equivalents and produces an alkalinizing effect. The product is a hypertonic, single-dose intravenous solution without bacteriostatic or antimicrobial preservatives, originally developed by Hospira and marketed by Pfizer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium chloride dihydrate + dextrose monohydrate + potassium chloride + sodium chloride + sodium lactate.